We are live on
!
Find out more
Atossa Therapeutics
ATOS
ATOS
11 hedge funds and large institutions have $478K invested in Atossa Therapeutics in 2017 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
10% more funds holding
Funds holding: 10 → 11 (+1)
1% more capital invested
Capital invested by funds: $472K → $478K (+$6K)
0.03% less ownership
Funds ownership: 0.07% → 0.04% (-0.03%)
Holders
11
Holders Change
+1
Holders Change %
+10%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
2
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$76.2K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$63.9K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$22.1K |
| 4 |
VF
Virtu Financial
New York
|
+$20.1K |
| 5 |
GLA
Good Life Advisors
Reading,
Pennsylvania
|
+$8.97K |